EMEA-002441-PIP01-18

Key facts

Active substance
Technetium (99mTc) trofolastat chloride
Therapeutic area
Oncology
Decision number
P/0052/2019
PIP number
EMEA-002441-PIP01-18
Pharmaceutical form(s)
Kit for radiopharmaceutical preparation
Condition(s) / indication(s)
Visualisation of prostate specific membrane antigen in prostate cancer
Route(s) of administration
Intravenous use
Contact for public enquiries
ROTOP Pharmaka GmbH

Tel.  +49 35126310251
E-mail: f.klein@rotop-pharmaka.de

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating